In the search for medication against Alzheimer's disease, scientists have focused on -- among other factors -- drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the known plaques in the brains of Alzheimer's patients. The starting point for the formation of A-beta is APP.